These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12812511)

  • 21. Rapid protein-ligand costructures using chemical shift perturbations.
    Stark J; Powers R
    J Am Chem Soc; 2008 Jan; 130(2):535-45. PubMed ID: 18088118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors.
    Meyer B; Peters T
    Angew Chem Int Ed Engl; 2003 Feb; 42(8):864-90. PubMed ID: 12596167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery.
    Vanwetswinkel S; Heetebrij RJ; van Duynhoven J; Hollander JG; Filippov DV; Hajduk PJ; Siegal G
    Chem Biol; 2005 Feb; 12(2):207-16. PubMed ID: 15734648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput nuclear magnetic resonance-based screening.
    Hajduk PJ; Gerfin T; Boehlen JM; Häberli M; Marek D; Fesik SW
    J Med Chem; 1999 Jul; 42(13):2315-7. PubMed ID: 10395471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry.
    Crump MP; Ceska TA; Spyracopoulos L; Henry A; Archibald SC; Alexander R; Taylor RJ; Findlow SC; O'Connell J; Robinson MK; Shock A
    Biochemistry; 2004 Mar; 43(9):2394-404. PubMed ID: 14992576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMR methods in fragment screening: theory and a comparison with other biophysical techniques.
    Dalvit C
    Drug Discov Today; 2009 Nov; 14(21-22):1051-7. PubMed ID: 19716431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMR studies of protein-ligand interactions.
    Maurer T
    Methods Mol Biol; 2005; 305():197-214. PubMed ID: 15939999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-ligand NOE matching: a high-throughput method for binding pose evaluation that does not require protein NMR resonance assignments.
    Constantine KL; Davis ME; Metzler WJ; Mueller L; Claus BL
    J Am Chem Soc; 2006 Jun; 128(22):7252-63. PubMed ID: 16734479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competition saturation transfer difference experiments improved with isotope editing and filtering schemes in NMR-based screening.
    Fehér K; Groves P; Batta G; Jiménez-Barbero J; Muhle-Goll C; Kövér KE
    J Am Chem Soc; 2008 Dec; 130(50):17148-53. PubMed ID: 19053472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saturation transfer difference nuclear magnetic resonance study on the specific binding of ligand to protein.
    Ji Z; Yao Z; Liu M
    Anal Biochem; 2009 Feb; 385(2):380-2. PubMed ID: 19070584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-resolution, high-sensitivity NMR of nanolitre anisotropic samples by coil spinning.
    Sakellariou D; Le Goff G; Jacquinot JF
    Nature; 2007 Jun; 447(7145):694-7. PubMed ID: 17554303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens.
    Huth JR; Mendoza R; Olejniczak ET; Johnson RW; Cothron DA; Liu Y; Lerner CG; Chen J; Hajduk PJ
    J Am Chem Soc; 2005 Jan; 127(1):217-24. PubMed ID: 15631471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements.
    Lucas LH; Price KE; Larive CK
    J Am Chem Soc; 2004 Nov; 126(43):14258-66. PubMed ID: 15506793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mutagenesis-free approach to assignment of (19)F NMR resonances in biosynthetically labeled proteins.
    Kitevski-LeBlanc JL; Al-Abdul-Wahid MS; Prosser RS
    J Am Chem Soc; 2009 Feb; 131(6):2054-5. PubMed ID: 19173647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quadrupole-central-transition 17O NMR spectroscopy of protein-ligand complexes in solution.
    Zhu J; Kwan IC; Wu G
    J Am Chem Soc; 2009 Oct; 131(40):14206-7. PubMed ID: 19764760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robust NMR screening for lead compounds using tryptophan-containing proteins.
    Bista M; Kowalska K; Janczyk W; Dömling A; Holak TA
    J Am Chem Soc; 2009 Jun; 131(22):7500-1. PubMed ID: 19422216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR studies of 4-19F-phenylalanine-labeled intestinal fatty acid binding protein: evidence for conformational heterogeneity in the native state.
    Li H; Frieden C
    Biochemistry; 2005 Feb; 44(7):2369-77. PubMed ID: 15709749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How much NMR data is required to determine a protein-ligand complex structure?
    Schieborr U; Vogtherr M; Elshorst B; Betz M; Grimme S; Pescatore B; Langer T; Saxena K; Schwalbe H
    Chembiochem; 2005 Oct; 6(10):1891-8. PubMed ID: 16013076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMR-based screening of membrane protein ligands.
    Yanamala N; Dutta A; Beck B; van Fleet B; Hay K; Yazbak A; Ishima R; Doemling A; Klein-Seetharaman J
    Chem Biol Drug Des; 2010 Mar; 75(3):237-56. PubMed ID: 20331645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of protein-ligand interactions by high-resolution solid-state NMR spectroscopy.
    Zech SG; Olejniczak E; Hajduk P; Mack J; McDermott AE
    J Am Chem Soc; 2004 Nov; 126(43):13948-53. PubMed ID: 15506755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.